KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. por Kuhen, K, Chatterjee, A, Rottmann, M, Gagaring, K, Borboa, R, Buenviaje, J, Chen, Z, Francek, C, Wu, T, Nagle, A, Barnes, S, Plouffe, D, Lee, M, Fidock, D, Graumans, W, van de Vegte-Bolmer, M, van Gemert, G, Wirjanata, G, Sebayang, B, Marfurt, J, Russell, B, Suwanarusk, R, Price, R, Nosten, F, Tungtaeng, A, Gettayacamin, M, Sattabongkot, J, Taylor, J, Walker, J, Tully, D, Patra, K, Flannery, E, Vinetz, J, Renia, L, Sauerwein, R, Winzeler, E, Glynne, R, Diagana, T